|
Volumn 17, Issue 4, 1994, Pages 352-371
|
ASDA standards of practice: Narcolepsy and its treatment with stimulants
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
4 HYDROXYBUTYRIC ACID;
AMPHETAMINE;
COCAINE;
CODEINE SULFATE;
DEXAMPHETAMINE;
FENCAMFAMIN;
MAZINDOL;
METHAMPHETAMINE;
METHYLPHENIDATE;
MODAFINIL;
PEMOLINE MAGNESIUM;
PROPRANOLOL;
SELEGILINE;
TYROSINE;
UNCLASSIFIED DRUG;
CENTRAL STIMULANT AGENT;
ANXIETY;
CATAPLEXY;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG EFFECT;
DRUG STRUCTURE;
HALLUCINATION;
HEADACHE;
HEART PALPITATION;
HUMAN;
INSOMNIA;
NARCOLEPSY;
NERVOUSNESS;
PARALYSIS;
PRIORITY JOURNAL;
REVIEW;
SOMNOLENCE;
ADOLESCENT;
ADULT;
AROUSAL;
CHILD;
DRUG ADMINISTRATION;
FEMALE;
MALE;
PRACTICE GUIDELINE;
PREGNANCY;
RISK FACTOR;
ADOLESCENT;
ADULT;
AROUSAL;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMAN;
MALE;
NARCOLEPSY;
PREGNANCY;
RISK FACTORS;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0028122506
PISSN: 01618105
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (163)
|
References (0)
|